In recent months, Vor Biopharma closed a US$424.83 million shelf registration, repriced employee stock options, and reported positive late-stage clinical data for its autoimmune drug candidate ...

Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...

Vor Biopharma Inc. (NASDAQ:VOR) on Tuesday priced an underwritten public offering of 10 million shares at $10.00 per share. The gross proceeds from the offering are expected to be $100 million. In ...

Although design thinking is a common approach in the business community, its use for guiding development and adaptation processes is not yet common practice in the context of digital mental health.

I love being a licensed private pilot. As you may have seen from other videos, I am starting my instrument rating training. I really believe that I will be a much safer pilot when I get my IFR or ...

While Vor provided no details on the results, the company is now evaluating a global trial of the drug in the chronic immune condition. Vor hit reset in May, after nearly a decade of work on blood ...

FRIDAY: A customer flew in from Lubbock for a couple of VOR approaches, then back in his Piper Cherokee 180. Mark Parish flew locally in his Cessna 182 Skylane. Med-Trans flew over to Covenant Health ...

H.C. Wainwright upgraded Vor Biopharma Inc. (NASDAQ:VOR), highlighting the company’s “rebirth” following the in-licensing of telitacicept. On Thursday, the company announced a strategic licensing ...

In the lead-up to Game Informer's return back in March, I wanted to replay two of my favorite short, instant-action experiences. I hadn’t played Super Mario 64 or Portal all the way through since ...